Glass Wall Systems (India) Limited (GLASSWALL)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- H1 FY27 revenue grew 16% y-y to Rs.239 Cr; EBITDA margin expanded to 25.3%
- Order book at Rs.957 Cr as of Sep 30, 2026, with Rs.500 Cr expected in next 2 quarters
- Domestic revenue up 33% y-y; export revenue down 14% y-y due to timing
- Glass processing unit commissioning expected by Jul-Aug 2027, adding 1-1.5% EBITDA margin
- Fenestration segment revenue up 82% y-y; luxury residential projects driving growth
- Export market cautious due to US midterm elections and commodity price volatility
- FY27 revenue growth guidance maintained at 20-22%, margins stable at 23-25% EBITDA
- Working capital days improved to negative 19 days, indicating strong cash flow
- Management focused on selective order booking from Rs.3,000 Cr pipeline to maintain execution quality
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 GLASSWALL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add GLASSWALL to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Glass Wall Systems (India) Limited
Important.
The summary above is generated automatically from Glass Wall Systems (India) Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.